Literature DB >> 12039028

Signaling through the JAK/STAT pathway, recent advances and future challenges.

T Kisseleva1, S Bhattacharya, J Braunstein, C W Schindler.   

Abstract

Investigation into the mechanism of cytokine signaling led to the discovery of the JAK/STAT pathway. Following the binding of cytokines to their cognate receptor, signal transducers and activators of transcription (STATs) are activated by members of the janus activated kinase (JAK) family of tyrosine kinases. Once activated, they dimerize and translocate to the nucleus and modulate the expression of target genes. During the past several years significant progress has been made in the characterization of the JAK/STAT signaling cascade, including the identification of multiple STATs and regulatory proteins. Seven STATs have been identified in mammals. The vital role these STATs play in the biological response to cytokines has been demonstrated through the generation of murine 'knockout' models. These mice will be invaluable in carefully elucidating the role STATs play in regulating the host response to various stresses. Similarly, the solution of the crystal structure of two STATs has and will continue to facilitate our understanding of how STATs function. This review will highlight these exciting developments in JAK/STAT signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039028     DOI: 10.1016/s0378-1119(02)00398-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  317 in total

Review 1.  Series introduction. JAK-STAT signaling in human disease.

Authors:  Christian W Schindler
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Signaling of cytokines is important in regulation of GnRH neurons.

Authors:  Sheng Wu; Andrew Wolfe
Journal:  Mol Neurobiol       Date:  2011-12-13       Impact factor: 5.590

3.  DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1.

Authors:  Thomas Meyer; Andreas Marg; Petra Lemke; Burkhard Wiesner; Uwe Vinkemeier
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

4.  Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion.

Authors:  Maria Cecilia S Freitas; Yoichiro Uchida; Danyun Zhao; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2010-05       Impact factor: 5.799

5.  Characterization of a highly effective protein substrate for analysis of JAK2(V617F) Activity.

Authors:  Zhe Li; Shu Xing; Shaofeng Wang; Wanting Tina Ho; Zhizhuang Joe Zhao
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

6.  Ciliary neurotrophic factor protects mice against streptozotocin-induced type 1 diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death.

Authors:  Luiz F Rezende; Gustavo J Santos; Everardo M Carneiro; Antonio C Boschero
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

7.  Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis.

Authors:  Xinhai Yang; Dianhua Qiao; Kristy Meyer; Andreas Friedl
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

8.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 9.  Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand.

Authors:  Nor Saadah M Azahri; Mary M Kavurma
Journal:  Cell Mol Life Sci       Date:  2013-01-18       Impact factor: 9.261

10.  Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic-inorganic inhibitors.

Authors:  Matthew B Minus; Haopei Wang; Jaime O Munoz; Alexandra M Stevens; Alicia E Mangubat-Medina; Michael J Krueger; Wei Liu; Moses M Kasembeli; Julian C Cooper; Mikhail I Kolosov; David J Tweardy; Michele S Redell; Zachary T Ball
Journal:  Org Biomol Chem       Date:  2020-05-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.